Rescue right ventricular outflow tract stenting for refractory hypoxic spells
Background While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear. Methods Patients who underwent RVOTS for emergency relie...
Saved in:
Published in | Catheterization and cardiovascular interventions Vol. 101; no. 2; pp. 372 - 378 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear.
Methods
Patients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire.
Results
From 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5–442.5); weight 3.27 kg (2.7–8.96); 9 males. Median pulmonary annulus Z score was −4.13 (IQR−4.85 to −0.86). Thirteen stents with median diameter 5 (4–6.5) mm and length 19 (16–19.75) mm were implanted, fluoroscopy time:13.6 (11–26.3) min; procedure time (60, 30–70 min). All were ventilated. Oxygen saturations improved from 45% (40–60) to 90% (84–92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20–49) hours and 4 required diuretic infusion for pulmonary over‐circulation. Four needed re‐stenting 13 days to 5 months later. At median follow‐up of 7 (4–17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto‐pulmonary shunt) and 6 await surgery.
Conclusion
RVOTS enables safe, expeditious and effective short‐term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness. |
---|---|
AbstractList | BackgroundWhile right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear.MethodsPatients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire.ResultsFrom 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5–442.5); weight 3.27 kg (2.7–8.96); 9 males. Median pulmonary annulus Z score was −4.13 (IQR−4.85 to −0.86). Thirteen stents with median diameter 5 (4–6.5) mm and length 19 (16–19.75) mm were implanted, fluoroscopy time:13.6 (11–26.3) min; procedure time (60, 30–70 min). All were ventilated. Oxygen saturations improved from 45% (40–60) to 90% (84–92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20–49) hours and 4 required diuretic infusion for pulmonary over‐circulation. Four needed re‐stenting 13 days to 5 months later. At median follow‐up of 7 (4–17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto‐pulmonary shunt) and 6 await surgery.ConclusionRVOTS enables safe, expeditious and effective short‐term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness. While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear.BACKGROUNDWhile right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear.Patients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire.METHODSPatients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire.From 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5-442.5); weight 3.27 kg (2.7-8.96); 9 males. Median pulmonary annulus Z score was -4.13 (IQR-4.85 to -0.86). Thirteen stents with median diameter 5 (4-6.5) mm and length 19 (16-19.75) mm were implanted, fluoroscopy time:13.6 (11-26.3) min; procedure time (60, 30-70 min). All were ventilated. Oxygen saturations improved from 45% (40-60) to 90% (84-92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20-49) hours and 4 required diuretic infusion for pulmonary over-circulation. Four needed re-stenting 13 days to 5 months later. At median follow-up of 7 (4-17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto-pulmonary shunt) and 6 await surgery.RESULTSFrom 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5-442.5); weight 3.27 kg (2.7-8.96); 9 males. Median pulmonary annulus Z score was -4.13 (IQR-4.85 to -0.86). Thirteen stents with median diameter 5 (4-6.5) mm and length 19 (16-19.75) mm were implanted, fluoroscopy time:13.6 (11-26.3) min; procedure time (60, 30-70 min). All were ventilated. Oxygen saturations improved from 45% (40-60) to 90% (84-92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20-49) hours and 4 required diuretic infusion for pulmonary over-circulation. Four needed re-stenting 13 days to 5 months later. At median follow-up of 7 (4-17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto-pulmonary shunt) and 6 await surgery.RVOTS enables safe, expeditious and effective short-term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness.CONCLUSIONRVOTS enables safe, expeditious and effective short-term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness. While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear. Patients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire. From 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5-442.5); weight 3.27 kg (2.7-8.96); 9 males. Median pulmonary annulus Z score was -4.13 (IQR-4.85 to -0.86). Thirteen stents with median diameter 5 (4-6.5) mm and length 19 (16-19.75) mm were implanted, fluoroscopy time:13.6 (11-26.3) min; procedure time (60, 30-70 min). All were ventilated. Oxygen saturations improved from 45% (40-60) to 90% (84-92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20-49) hours and 4 required diuretic infusion for pulmonary over-circulation. Four needed re-stenting 13 days to 5 months later. At median follow-up of 7 (4-17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto-pulmonary shunt) and 6 await surgery. RVOTS enables safe, expeditious and effective short-term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness. Background While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar physiologies, its utility for relief of refractory hypoxic spells is unclear. Methods Patients who underwent RVOTS for emergency relief of refractory hypoxic spells were identified. Specific modifications to enable expeditious RVOTS included use of stent delivery systems (guiding catheter or long sheath) upfront to minimize catheter exchanges; using coronary wires to cross RVOT initially; stabilizing the catheter with a wire in the aorta while crossing RVOT with a second wire. Results From 2015 to 2022, 11 patients underwent RVOTS for hypoxic spells refractory to medical management. Their median age was 27 days (IQR 8.5–442.5); weight 3.27 kg (2.7–8.96); 9 males. Median pulmonary annulus Z score was −4.13 (IQR−4.85 to −0.86). Thirteen stents with median diameter 5 (4–6.5) mm and length 19 (16–19.75) mm were implanted, fluoroscopy time:13.6 (11–26.3) min; procedure time (60, 30–70 min). All were ventilated. Oxygen saturations improved from 45% (40–60) to 90% (84–92); (p < 0.0001) with no major complications. Postprocedure ventilation was needed for 21 (20–49) hours and 4 required diuretic infusion for pulmonary over‐circulation. Four needed re‐stenting 13 days to 5 months later. At median follow‐up of 7 (4–17) months; 2 died from unrelated causes, 3 underwent surgery (two correction and one aorto‐pulmonary shunt) and 6 await surgery. Conclusion RVOTS enables safe, expeditious and effective short‐term palliation for refractory hypoxic spells. Specific technical modifications facilitate safety, ease and swiftness. |
Author | Balaji, Seshadri Sasikumar, Navaneetha Kumar, Raman Krishna Mohanty, Satish |
Author_xml | – sequence: 1 givenname: Navaneetha orcidid: 0000-0001-8621-8235 surname: Sasikumar fullname: Sasikumar, Navaneetha email: drnavni@yahoo.com organization: Amrita Institute of Medical Sciences – sequence: 2 givenname: Satish surname: Mohanty fullname: Mohanty, Satish organization: Amrita Institute of Medical Sciences – sequence: 3 givenname: Seshadri orcidid: 0000-0001-5864-5125 surname: Balaji fullname: Balaji, Seshadri organization: Oregon Health & Science University – sequence: 4 givenname: Raman Krishna surname: Kumar fullname: Kumar, Raman Krishna organization: Amrita Institute of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36511421$$D View this record in MEDLINE/PubMed |
BookMark | eNp90TtPwzAQAGALFdEHDPwBZIkFhra24yTNiMJTKkJCHdiixLm0rtI42A4l_x6HFoZKMPn13el8N0S9SlWA0DklE0oImwqRTzziM3aEBtQt45AFb739nkY86KOhMWtCSBSw6AT1vcCnlDM6QM-vYEQDWMvlyuIPqKyWoilTjVVji1JtsdWpsNhY9ySrJS6UxhqK7lLpFq_aWn1KgU0NZWlO0XGRlgbO9usILe7vFvHjeP7y8BTfzMfC8z1XHogZ4X4ehKFICWeCk5yCV7AwcKeAk5nICh5xngFENKMiysCJWUBEAYR7I3S1S1tr9d6AsclGGuEKSCtQjUlY6HPCI0Y7enlA16rRlSvOqTB0kvidutirJttAntRablLdJj99cuB6B4RWxrj__xJKkm4GiZtB8j0DZ6cHVkibWqlcb1NZ_hexlSW0f6dO4vh2F_EFuZGWjQ |
CitedBy_id | crossref_primary_10_1016_j_ppedcard_2024_101748 crossref_primary_10_1007_s00246_024_03496_8 crossref_primary_10_4103_apc_apc_196_24 crossref_primary_10_4103_cmi_cmi_10_24 crossref_primary_10_1016_j_ppedcard_2025_101822 |
Cites_doi | 10.1136/heartjnl-2013-304155 10.1016/j.jtcvs.2020.06.008 10.1017/S1047951120002334 10.1161/CIRCULATIONAHA.117.029987 10.1136/hrt.2007.135723 10.1161/CIRCINTERVENTIONS.113.000202 10.1161/CIRCINTERVENTIONS.116.003979 10.1161/CIRCINTERVENTIONS.111.965616 10.1016/j.jcin.2017.06.023 10.1007/s00246-021-02684-0 10.1002/ccd.21928 10.1186/s12872-020-01817-2 10.1111/joic.12198 10.1161/CIRCINTERVENTIONS.120.009520 |
ContentType | Journal Article |
Copyright | 2022 Wiley Periodicals LLC. 2023 Wiley Periodicals LLC. |
Copyright_xml | – notice: 2022 Wiley Periodicals LLC. – notice: 2023 Wiley Periodicals LLC. |
DBID | AAYXX CITATION NPM 7T5 7U9 H94 K9. 7X8 |
DOI | 10.1002/ccd.30522 |
DatabaseName | CrossRef PubMed Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1522-726X |
EndPage | 378 |
ExternalDocumentID | 36511421 10_1002_ccd_30522 CCD30522 |
Genre | article Journal Article |
GroupedDBID | --- .3N .GA 05W 0R~ 10A 1L6 1OC 29B 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K ROL RWI RX1 SUPJJ SV3 TEORI UB1 V2E W8V W99 WBKPD WHWMO WIH WIJ WIK WJL WOHZO WQJ WRC WVDHM WXI WXSBR XG1 XPP XV2 ~IA ~WT .GJ .Y3 31~ 53G AANHP AAQQT AASGY AAYXX ACBWZ ACRPL ACYXJ ADNMO AEYWJ AGHNM AGQPQ AGYGG AZFZN CITATION EJD FEDTE HF~ HVGLF LW6 ZGI AAMMB AEFGJ AGXDD AIDQK AIDYY NPM 7T5 7U9 H94 K9. 7X8 |
ID | FETCH-LOGICAL-c3532-7ec8045d677ca042c40d1e3f2760426408cbf4944bee91b1c9be0d1860cfe043 |
IEDL.DBID | DR2 |
ISSN | 1522-1946 1522-726X |
IngestDate | Fri Jul 11 15:02:44 EDT 2025 Fri Jul 25 23:58:12 EDT 2025 Mon Jul 21 06:07:49 EDT 2025 Thu Apr 24 22:52:05 EDT 2025 Tue Jul 01 02:16:05 EDT 2025 Wed Jan 22 16:19:17 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Tetralogy of Fallot hypoxic spells catheter intervention right ventricular outflow tract stenting |
Language | English |
License | 2022 Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3532-7ec8045d677ca042c40d1e3f2760426408cbf4944bee91b1c9be0d1860cfe043 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-8621-8235 0000-0001-5864-5125 |
PMID | 36511421 |
PQID | 2777275054 |
PQPubID | 986345 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2754049214 proquest_journals_2777275054 pubmed_primary_36511421 crossref_primary_10_1002_ccd_30522 crossref_citationtrail_10_1002_ccd_30522 wiley_primary_10_1002_ccd_30522_CCD30522 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 1, 2023 |
PublicationDateYYYYMMDD | 2023-02-01 |
PublicationDate_xml | – month: 02 year: 2023 text: February 1, 2023 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationTitle | Catheterization and cardiovascular interventions |
PublicationTitleAlternate | Catheter Cardiovasc Interv |
PublicationYear | 2023 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2021; 14 2015; 28 2021; 21 2009; 74 2009; 95 2013; 99 2020; 30 2017; 10 2018; 137 2021; 161 2022; 43 2011; 4 2013; 6 2016; 9 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 |
References_xml | – volume: 28 start-page: 279 issue: 3 year: 2015 end-page: 287 article-title: Investigators of the working group interventional cardiology of the German society of pediatric cardiology. Stenting of native right ventricular outflow tract obstructions in symptomatic infants publication-title: J Interv Cardiol – volume: 10 start-page: 1774 issue: 17 year: 2017 end-page: 1784 article-title: Stenting of the right ventricular outflow tract promotes better pulmonary arterial growth compared with modified Blalock‐Taussig shunt palliation in tetralogy of fallot‐type lesions publication-title: JACC Cardiovasc Interv – volume: 21 start-page: 9 issue: 1 year: 2021 article-title: Arterial duct stent versus surgical shunt for patients with duct‐dependent pulmonary circulation: a meta‐analysis publication-title: BMC Cardiovasc Disord – volume: 4 start-page: 602 issue: 6 year: 2011 end-page: 614 article-title: Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient‐related and procedural risk factors in the US Melody Valve Trial publication-title: Circ Cardiovasc Interv – volume: 74 start-page: 144 issue: 1 year: 2009 end-page: 147 article-title: Coronary compression caused by stenting a right pulmonary artery conduit publication-title: Catheter Cardiovasc Interv – volume: 99 start-page: 1603 year: 2013 end-page: 1608 article-title: Stenting of the right ventricular outflow tract publication-title: Heart – volume: 6 start-page: 535 year: 2013 end-page: 542 article-title: Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience publication-title: Circ Cardiovasc Interv – volume: 9 issue: 12 year: 2016 article-title: Right ventricular outflow tract stenting in tetralogy of fallot infants with risk factors for early primary repair publication-title: Circ Cardiovasc Interv – volume: 161 start-page: 379 issue: 2 year: 2021 end-page: 390 article-title: Duct stenting versus modified Blalock‐Taussig shunt in neonates and infants with duct‐dependent pulmonary blood flow: a systematic review and meta‐ analysis publication-title: J Thorac Cardiovasc Surg – volume: 95 start-page: 142 issue: 2 year: 2009 end-page: 147 article-title: Stenting of the right ventricular outflow tract in the symptomatic infant with tetralogy of Fallot publication-title: Heart – volume: 137 start-page: 589 issue: 6 year: 2018 end-page: 601 article-title: Comparison between patent ductus arteriosus stent and modified Blalock‐ Taussig shunt as palliation for infants with ductal‐dependent pulmonary blood flow: insights from the congenital catheterization research collaborative publication-title: Circulation – volume: 14 issue: 3 year: 2021 article-title: Patent ductus arteriosus stenting for all ductal‐dependent cyanotic infants: waning use of Blalock‐Taussig shunts publication-title: Circ Cardiovasc Interv – volume: 43 start-page: 8 issue: 1 year: 2022 end-page: 16 article-title: Coronary artery anomalies and their impact on the feasibility of percutaneous pulmonary valve implantation publication-title: Pediatr Cardiol – volume: 30 start-page: 1469 issue: 10 year: 2020 end-page: 1472 article-title: Catheter‐based palliation for infants with tetralogy of Fallot publication-title: Cardiol Young – ident: e_1_2_7_4_1 doi: 10.1136/heartjnl-2013-304155 – ident: e_1_2_7_9_1 doi: 10.1016/j.jtcvs.2020.06.008 – ident: e_1_2_7_2_1 doi: 10.1017/S1047951120002334 – ident: e_1_2_7_10_1 doi: 10.1161/CIRCULATIONAHA.117.029987 – ident: e_1_2_7_3_1 doi: 10.1136/hrt.2007.135723 – ident: e_1_2_7_12_1 doi: 10.1161/CIRCINTERVENTIONS.113.000202 – ident: e_1_2_7_6_1 doi: 10.1161/CIRCINTERVENTIONS.116.003979 – ident: e_1_2_7_15_1 doi: 10.1161/CIRCINTERVENTIONS.111.965616 – ident: e_1_2_7_11_1 doi: 10.1016/j.jcin.2017.06.023 – ident: e_1_2_7_13_1 doi: 10.1007/s00246-021-02684-0 – ident: e_1_2_7_14_1 doi: 10.1002/ccd.21928 – ident: e_1_2_7_8_1 doi: 10.1186/s12872-020-01817-2 – ident: e_1_2_7_5_1 doi: 10.1111/joic.12198 – ident: e_1_2_7_7_1 doi: 10.1161/CIRCINTERVENTIONS.120.009520 |
SSID | ssj0009629 |
Score | 2.400474 |
Snippet | Background
While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and... While right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and similar... BackgroundWhile right ventricular outflow tract stenting (RVOTS) has become an acceptable alternative to palliative surgery in Tetralogy of Fallot (TOF) and... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 372 |
SubjectTerms | Aorta Cardiovascular disease catheter intervention Catheters Congenital diseases Diuretics Fluoroscopy Heart Hypoxia hypoxic spells Implants Palliation Patients right ventricular outflow tract stenting Surgery Tetralogy of Fallot Ventricle |
Title | Rescue right ventricular outflow tract stenting for refractory hypoxic spells |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fccd.30522 https://www.ncbi.nlm.nih.gov/pubmed/36511421 https://www.proquest.com/docview/2777275054 https://www.proquest.com/docview/2754049214 |
Volume | 101 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7iQbz4fqwvonjw0jVJ07TFk6yKCOtBFDwIJUlTFJetbFt8_Hon6UN8gXgrdErSZCb5Jpn5BqH9WBJFJcs8mqrA4wZMUflUepFIQxKkREahTXAeXorzG35xG9xOoaM2F6bmh-gO3KxluPXaGrhUxeEHaajWaR-Uldn118ZqWUB09UEdFQtXoQy2J-aBoy5aViHCDrsvP-9F3wDmZ7zqNpyzeXTXdrWOM3nsV6Xq67cvLI7__JcFNNcAUXxca84imjLjJTQzbK7al9HwyhS6Mth579hGRbqjQjnBeVVmo_wZlzbBCoOWuGITGNAvhl-cuAI-r_j-9Sl_edC4sNc7xQq6Pju9Hpx7Te0FT_uBD6Db6AjQXirCUEswbM1JSo2fsVBYr4uTSKuMx5wrY2KqqI6VAYlIEJ0Zwv1VND3Ox2YdYUIUYEgDME34XNJMpT6ACE2pClimhd9DB-0kJLrhJbflMUZJzajMEhidxI1OD-11ok81GcdPQlvtTCaNPRYJC8GLAHAU8B7a7V6DJdnrETk2eWVlAL3ymFGQWas1oGsF9MsmHVPorJvH35tPBoMT97Dxd9FNNGur2NfB4FtoupxUZhuwTql2nFK_A0nP-CI |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hkFouhZZHl0Jxqx56yeJXnETqBS1F25blgLYSFxTFjqNWRRu0m6jAr2fsPBC0lSpukTKRHXvG_saP7wP4kGRUs4wXAct1GEiLoagFy4JY5RENc5rFkbvgPDlV4-_y63l4vgSfurswDT9Ev-DmIsOP1y7A3YL0wT1rqDH5EL2V4wC84hS9fUJ1dk8elSivUYYTFA8wVVcdrxDlB_2nD2ejPyDmQ8Tqp5zjNbjoKtucNPk1rCs9NLePeByf-jfr8KLFouSwcZ6XsGRnr-DZpN1t34DJmV2Y2hKfwBN3MNKvFmZzUtZVcVn-JpW7Y0XQUbzeBEEATPAf517D54b8uLkqr38asnA7PItNmB5_no7GQSu_EBgRCsTd1sQI-HIVRSbD2DaS5syKgkfKJV6SxkYXMpFSW5swzUyiLVrEiprCUim2YHlWzuxrIJRqhJEWkZoSMmOFzgXiCMOYDnlhlBjAx64XUtNSkzuFjMu0IVXmKbZO6ltnAO9706uGj-NvRrtdV6ZtSC5SHmEigfgolAN417_GYHI7JNnMlrWzQQArE87QZrtxgb4UgS7GJGdYWd-R_y4-HY2O_MPO_5vuw_PxdHKSnnw5_fYGVp2ofXM2fBeWq3lt9xD6VPqt9_A7zDP8PQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEB5CAqEvSXok2SRt1dKHvnijy7JNn8pul6TthhJSyEPAWLJMSsN62bXJ8es7ko-QHlDyZvAIXTPSN5LmG4B3SUY1y3gRsFyHgbRoilqwLIhVHtEwp1kcuQDn6Yk6-i4_n4fnK_Chi4Vp-CH6AzdnGX69dgY-z4vDe9JQY_IhKivH9XdNKho7lR6f3nNHJcqnKMP9iQfoqauOVojyw77ow83oD4T5ELD6HWeyCRddW5uHJj-HdaWH5u43GsdHdmYLNlokSj42qvMUVuzsGaxP27v25zA9tUtTW-Ldd-KeRfqzwmxByroqrsprUrkIK4Jq4rNNEIS_BLu48Bl8bsnl7by8-WHI0t3vLF_A2eTT2egoaJMvBEaEAlG3NTHCvVxFkcnQso2kObOi4JFybpeksdGFTKTU1iZMM5NoixKxoqawVIptWJ2VM7sLhFKNINIiTlNCZqzQuUAUYRjTIS-MEgN4301Calpicpcf4yptKJV5iqOT-tEZwNtedN6wcfxN6KCbybQ1yGXKI3QjEB2FcgBv-t9oSu5-JJvZsnYyCF9lwhnK7DQa0NciVOiijhk21s_jv6tPR6Ox_9j7f9HXsP5tPEm_Hp982YcnLqN98zD8AFarRW1fIu6p9Cuv378A9LD69Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rescue+right+ventricular+outflow+tract+stenting+for+refractory+hypoxic+spells&rft.jtitle=Catheterization+and+cardiovascular+interventions&rft.au=Sasikumar%2C+Navaneetha&rft.au=Mohanty%2C+Satish&rft.au=Balaji%2C+Seshadri&rft.au=Kumar%2C+Raman+Krishna&rft.date=2023-02-01&rft.issn=1522-1946&rft.eissn=1522-726X&rft.volume=101&rft.issue=2&rft.spage=372&rft.epage=378&rft_id=info:doi/10.1002%2Fccd.30522&rft.externalDBID=10.1002%252Fccd.30522&rft.externalDocID=CCD30522 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1522-1946&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1522-1946&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1522-1946&client=summon |